MedPath

Wool Clothing for the Management of Childhood Atopic Dermatitis

Not Applicable
Completed
Conditions
Dermatitis, Atopic
Interventions
Other: wool clothing
Registration Number
NCT02534428
Lead Sponsor
Murdoch Childrens Research Institute
Brief Summary

The study is a sequentially recruited, cross-over-cohort, outpatient-based evaluation of the effectiveness of wool clothing, as compared to standard clothing, in reducing the severity of childhood atopic dermatitis over two consecutive six-week periods.

Detailed Description

The study will aim for a sample size of approximately 40 patients between the ages of 0 and 3 years of children referred to the Dermatology Department at the Royal Children's Hospital for management of mild to moderate atopic dermatitis. They will be sequentially recruited and randomized to the wool-standard clothing arm or standard clothing-wool arm.

The study will run for 12 weeks for each participant with two 6-week periods, either of wool followed by standard clothing or standard followed by wool clothing. Participants will be assessed by a blinded trained researcher during this time, at their initial appointment, 3 weeks, 6 weeks, 9 weeks and 12 weeks.

The primary outcome is change in the severity of atopic eczema at 6 weeks. Severity of atopic eczema will be measured using the Scoring Atopic Dermatitis (SCORAD) index.

Secondary outcomes include the change in the severity of eczema using the SCORAD at 3 weeks and the Atopic Dermatitis Severity Index (ADSI) score at 3 and 6 weeks and quality of life assessment using the Dermatology Life Quality Index (DLQI) at 3 and 6 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • mild to moderate eczema as determined by a SCORAD of 1-50 at their initial visit
  • has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participants behalf
  • is capable of returning for review having had education through the Royal Children's Hospital eczema workshop
Read More
Exclusion Criteria
  • known reactions to wool products
  • is unable to attend visits
  • has unstable eczema defined by treatment escalation or increased topical anti-inflammatory use in the preceding 2 months
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
wool-first (wool-standard)wool clothingsuperfine merino wool clothing to be worn for 6 weeks followed by 6 weeks of standard clothing (cotton)
cotton-first (standard-wool)wool clothingstandard (cotton) clothing to be work for 6 weeks followed by 6 weeks of superfine merino wool clothing
Primary Outcome Measures
NameTimeMethod
Change in the SCORAD Scoring Atopic Dermatitis Index (Units on a scale)at 6 weeks

blinded assessor administered SCORAD

Secondary Outcome Measures
NameTimeMethod
Change in the SCORAD Scoring Atopic Dermatitis Index (Units on a scale)at 3 weeks

blinded assessor administered SCORAD

Change in ADSI Atopic Dermatitis Severity Index (Units on a scale)at 3 weeks

blinded assessor administered ADSI

Change in IDQOL Infant's Dermatitis Quality of Life index (Units on a scale)at 3 weeks
© Copyright 2025. All Rights Reserved by MedPath